secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aardvark Therapeutics, Inc. (AARD)
CIK:        0001774857
Form:       8-K
Filed at:   2026-06-12T20:05:17+00:00
Accession:  0001193125-26-269377
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aardvark Therapeutics awards retention bonuses to CFO and CMO totaling ~$703,500
--------------------------------------------------------------------------------

- CFO/COO Nelson Sun receives $346,500 retention bonus ($198k guaranteed 2026 annual + $148.5k retention).
- CMO Manasi Jaiman receives $357,000 retention bonus ($204k guaranteed 2026 annual + $153k retention).
- Both bonuses payable on Jan 1, 2027, subject to continued employment or termination without cause/good reason.
- Each officer must sign a release of claims to receive payment if employment ends before Jan 1, 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1774857/000119312526269377/0001193125-26-269377-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1774857/000119312526269377/ck0001774857-20260610.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-269377

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer